IDiyas

For the Inventor, By the Inventor

Inis Biotech LLC


USPTO Granted Patents = 20



Forward Citations = 60

Loading Chart...
Loading Chart...

161 inventors (with patents filed for the assignee):

goldMedal Ricardo Alfredo Dewey (2 out of 2 patents)

silverMedal Andrea Nancy Chisari (2 out of 2 patents)

bronzeMedal Benito Jorge Velasco Zamora (2 out of 2 patents)

4.  Diego Omar Croci Russo (2 out of 5 patents)

5.  Juan Pablo Cerliani (2 out of 3 patents)

6.  Mariana Salatino (2 out of 5 patents)

7.  Mario Humberto Rodriguez (2 out of 3 patents)

8.  Gabriel Rabinovich (2 out of 8 patents)

9.  Javier Alberto Ramirez (2 out of 3 patents)

10.  Flavia Mariana Michelini (2 out of 2 patents)

11.  Lydia Raquel Galagovsky (2 out of 2 patents)

12.  Alejandro Berra (2 out of 2 patents)

13.  Laura Edith Alche (2 out of 2 patents)

14.  Ana Romo (1 out of 1 patent)

15.  Anabela Belen La Colla (1 out of 1 patent)


20 patents:

1. 11835665 - Neutron and gamma radiation detector using a water Cherenkov detector (2023-12-05),
2. 11072647 - TGF-receptor II isoform, fusion peptide, methods of treatment and methods in vitro (2021-07-27),
3. 11020478 - Methods for modulating angiogenesis of cancers refractory to anti-VEGF treatment (2021-06-01),
4. 10857522 - Catalytic process for the production of propylene glycol from glycerol, a copper and cerium catalyst, and a process to produce such catalyst (2020-12-08),
5. 10490866 - Method for acid dissolution of LiCoOcontained in spent lithium-ion batteries (2019-11-26),
6. 10385114 - SPARC (secreted protein, acidic and rich in cysteine), a new target for the treatment and prevention of acute liver failure (2019-08-20),
7. 10294295 - Methods for modulating angiogenesis of cancers refractory to anti-VEGF treatment (2019-05-21),
8. 10259719 - Process for obtaining lithium from aluminosilicates and intermediate compounds (2019-04-16),
9. 10233227 - Isoform of the TGF-beta receptor II (2019-03-19),
10. 10000548 - GAL-1 variants having immuno-modulating properties and methods of using the same (2018-06-19),
11. 9733174 - Capillary microviscometer (2017-08-15),
12. 9657298 - Recombinant nitrogen-fixing bacterial strain, inoculum containing the same and application methods (2017-05-23),
13. 9623102 - [object Object] (2017-04-18),
14. 9511137 - Adjuvant for vaccines, vaccines that comprise said adjuvant and uses thereof (2016-12-06),
15. 9187518 - Antiangiogenic brassinosteroid compounds (2015-11-17),
INIS Biotech LLC is a biotechnology company specializing in the development of innovative therapeutics. Our mission is to improve patient outcomes by advancing novel treatment options. We leverage cutting-edge technologies and a diverse team of experts to tackle complex diseases and unlock new solutions. With a focus on precision medicine and personalized therapies, we strive to transform healthcare and make a significant impact on global health challenges.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

...
20 Patents

#56 in

#352 in

#30,297 in the World

Inis Biotech LLC

Forward Citations = 60

161 inventors:

goldMedal Ricardo Alfredo Dewey (2 out of 2 patents)

silverMedal Andrea Nancy Chisari (2 out of 2 patents)

bronzeMedal Benito Jorge Velasco Zamora (2 out of 2 patents)

4.  Diego Omar Croci Russo (2 out of 5 patents)

5.  Juan Pablo Cerliani (2 out of 3 patents)

Please report any incorrect information to support@idiyas.com
Loading…